Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2 Triple Negative Breast Neoplasms 1 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Anemia, Sickle Cell 1 Anemia 1 Adenocarcinoma 1

Interventions

Epoetin Alfa 55 Darbepoetin alfa 39 epoetin beta 14 ferric carboxymaltose 11 Lenalidomide 5 Cyclophosphamide 5 luspatercept 4 fludarabine phosphate 4 fludarabine 4 Erythropoietin 4 Cyclosporine 4 Cisplatin 4 Busulfan 4 Blood Transfusion 4 Biopsy 4 ACE-011 4 peginesatide 3 iron isomaltoside 1000 3 hematide 3 ferrous sulfate 3 ferric gluconate 3 Radiotherapy 3 Iron-Dextran Complex 3 Filgrastim 3 Ferric Oxide, Saccharated 3 Erythrocyte Transfusion 3 Antilymphocyte Serum 3 thymoglobulin 2 telapristone acetate 2 ruxolitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia × Erythrocyte Count × Clear all

NCT01648946 2012-11-06

TRICCOP

Instituto do Cancer do Estado de São Paulo

Phase 3 Unknown

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡